[{"NetIncomeLossConverted_1_Q1_USD":-205808000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-203327000.0,"CommonStockSharesOutstanding_0_Q1_shares":67422000.0,"StockholdersEquity_0_Q1_USD":1200333000.0,"EarningsPerShareBasic_1_Q1_USD":-3.07,"Assets_0_Q1_USD":1637279000.0,"CommonStockSharesConverted_0_Q1_shares":67422000.0,"RevenuesConverted_1_Q1_USD":12794000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]